FGP
TDOC icon

Freestone Grove Partners’s Teladoc Health TDOC Stock Holding History

Freestone Grove Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.34M Sell
865,349
-644,605
-43% -$4.29M 0.05% 317
2026
Q1 		$8.23M Buy
+1,509,954
New +$8.47M 0.06% 297
2025
Q2 		– Sell
-24,231
Closed -$193K – 848
2025
Q1 		$193K Sell
24,231
-153,420
-86% -$1.55M ﹤0.01% 543
2024
Q4 		$1.61M Buy
+177,651
New +$1.72M 0.02% 275

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Freestone Grove Partners's TDOC Position: Q2 2026 in Review

Freestone Grove Partners reduced its Teladoc Health (TDOC) stake by 43% in Q2 2026, selling an estimated $4.29M and leaving 865,349 shares worth $7.34M. The position accounts for 0.05% of the portfolio, ranked #317.

Freestone Grove Partners first reported a position in TDOC in Q4 2024 and has held it in 4 quarters since. The position peaked at $8.23M in Q1 2026. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Freestone Grove Partners held 865,349 shares of Teladoc Health worth $7.34M as of Q2 2026.
  • Freestone Grove Partners sold 644,605 Teladoc Health shares in Q2 2026, an estimated $4.29M.
  • Teladoc Health made up 0.05% of Freestone Grove Partners's portfolio in Q2 2026, its #317 holding.
  • Freestone Grove Partners first reported a position in Teladoc Health in Q4 2024 and has held it in 4 quarters since.
  • Freestone Grove Partners's Teladoc Health position peaked at $8.23M in Q1 2026.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.